Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$185.1 - $233.13 $98,658 - $124,258
-533 Reduced 27.98%
1,372 $317,000
Q2 2023

Aug 03, 2023

SELL
$224.99 - $256.14 $123,744 - $140,877
-550 Reduced 22.4%
1,905 $457,000
Q1 2023

May 04, 2023

BUY
$239.75 - $277.0 $13,426 - $15,512
56 Added 2.33%
2,455 $618,000
Q3 2022

Oct 31, 2022

SELL
$247.06 - $1507.4 $2,717 - $16,581
-11 Reduced 0.46%
2,399 $620,000
Q2 2022

Aug 01, 2022

SELL
$237.11 - $299.66 $59,514 - $75,214
-251 Reduced 9.43%
2,410 $611,000
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $20,415 - $24,932
-75 Reduced 2.74%
2,661 $810,000
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $103,216 - $119,507
486 Added 21.6%
2,736 $616,000
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $478,125 - $552,285
2,250 New
2,250 $500,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Harbor Advisory Corp Portfolio

Follow Harbor Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisory Corp , based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisory Corp with notifications on news.